Abstract
Currently, orthotopic liver transplantation is the gold standard therapy for liver failure. However, it is limited by the insufficient organ donor and risk of immune rejection. Stem cell therapy is a promising alternative treatment for liver failure. One of the most ideal sources of stem cells for regenerative medicine is adipose-derived stem cells (ADSCs). In this study, primary ADSCs seeded on cell culture insert were indirectly co-cultured with injured HepG2 to elucidate the role of ADSCs in promoting the recovery of injured HepG2 in non-contact manner. HepG2 recovery was determined by the surface area covered by cells and growth factor concentration was measured to identify the factors involved in regeneration. Besides, HepG2 were collected for q-PCR analysis of injury, hepatocyte functional and regenerative markers expression. For the ADSCs, expression of hepatogenic differentiation genes was analyzed. Results showed that non-contact co-culture with ADSCs helped the recovery of injured HepG2. ELISA quantification revealed that ADSCs secreted higher amount of HGF and VEGF to help the recovery of injured HepG2. Furthermore, HepG2 co-cultured with ADSCs expressed significantly lower injury markers as well as significantly higher regenerative and functional markers compared to the control HepG2. ADSCs co-cultured with injured HepG2 expressed significantly higher hepatic related genes compared to the control ADSCs. In conclusion, ADSCs promote recovery of injured HepG2 via secretion of HGF and VEGF. In addition, co-cultured ADSCs showed early sign of hepatogenic differentiation in response to the factors released or secreted by the injured HepG2.
Similar content being viewed by others
References
Banas A et al (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46:219–228
Banas A et al (2008) IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26:2705–2712
Banas A et al (2009) Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 24:70–77
Bansal MB (2016) Hepatic stellate cells: fibrogenic, regenerative or both? Heterogen Context Key Hepatol Int 10:902–908
Bönninghoff R et al (2012) Effect of different liver resection methods on liver damage and regeneration factors VEGF and FGF-2 in mice. Can J Surg 55:389
Cereghini S (1996) Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 10:267–282
Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (New York, NY) 274:1379–1383
Duncan AW, Dorrell C, Grompe M (2009) Stem cells and liver regeneration. Gastroenterology 137:466–481
Fitzpatrick E et al (2015) Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes. Cell Transpl 24:73–83
Gnecchi M, Zhang Z, Ni A, Dzau VJ (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204–1219
Hayato K, Rie T, Takeshi K, Shumpei I, Tsuyoshi I et al (2015) Adipose tissue-derived mesenchymal stem cells in regenerative medicine treatment for liver cirrhosis—focused on efficacy and safety in preclinical and clinical studies. JSM Regen Med Bio Eng 3(1):1012
Hioki O et al (1996) Expression and localization of basic fibroblast growth factor (bFGF) in the repair process of rat liver injury. J Hepatol 24:217–224
Hughes RD, Mitry RR, Dhawan A (2012) Current status of hepatocyte transplantation. Transplantation 93:342–347
Li GP, Wu LF, Pu ZJ (2008) Oxidative stress induces apoptosis in HepG2 cells. Chin J Pathophysiol 24:105–111. http://www.airitilibrary.com/Publication/alDetailedMesh?docid=10004718-200801-24-1-105-111-a
Li J, Li M, Niu B, Gong J (2011) Therapeutic potential of stem cell in liver regeneration. Front Med 5:26–32
Liau LL, Hui CK, Makpol S, Azurah AGN (2016) Hydrogen peroxide induces acute injury and up-regulates inflammatory gene expression in hepatocytes. Sains Malays 45:451–458
Lim J, Razi ZRM, Law J, Nawi AM, Idrus RBH, Ng MH (2016) MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord. Cytotherapy 18:1493–1502
Lim J et al. (2018) Mesenchymal stromal cells from the maternal segment of human umbilical cord is ideal for bone regeneration in allogenic setting. Tissue Eng Regen Med 15:75–87. https://doi.org/10.1007/s13770-017-0086-6
Merrill CL et al (2002) Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically. Toxicol Sci 68:93–101
Osawa Y et al (2002) Tumor necrosis factor alpha-induced interleukin-8 production via NF-κB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes. Infect Immun 70:6294–6301
Puglisi MA, Saulnier N, Piscaglia A, Tondi P, Agnes S, Gasbarrini A (2011) Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives. Eur Rev Med Pharmacol Sci 15:355–364
Ramadori G, Armbrust T (2001) Cytokines in the liver. Eur J Gastroenterol Hepatol 13:777–784
Secunda R, Vennila R, Mohanashankar A, Rajasundari M, Jeswanth S, Surendran R (2015) Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology 67:793–807
Selzner M, Graf R, Clavien P-A (2003) IL-6: A magic potion for liver transplantation? Gastroenterology 125:256–259
Seo MJ, Suh SY, Bae YC, Jung JS (2005) Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 328:258–264
Sgodda M et al (2007) Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res 313:2875–2886
Shiota G, Itaba N (2017) Progress in stem cell-based therapy for liver disease. Hepatol Res 47:127–141
Song G et al (2010) MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology 51:1735–1743
Tan Y, Raychaudhuri P, Costa RH (2007) Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol 27:1007–1016
Tanaka M, Miyajima A (2016) Liver regeneration and fibrosis after inflammation. Inflamm Regen 36:19
Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M (2001) Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 49:121–129
Turner MD, Nedjai B, Hurst T, Pennington DJ (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta Mol Cell Res 1843:2563–2582
Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells-current trends and future prospective. Biosci Rep 35:e00191
Acknowledgement
This work was supported by FRGS grant (Grant Number: UKM-FF-03-FRGS0165-2010) from Ministry of Higher Education (MOHE) of Malaysia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Liau, L.L., Makpol, S., Azurah, A.G.N. et al. Human adipose-derived mesenchymal stem cells promote recovery of injured HepG2 cell line and show sign of early hepatogenic differentiation. Cytotechnology 70, 1221–1233 (2018). https://doi.org/10.1007/s10616-018-0214-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-018-0214-8